Daniel Kaul, MD

Professor of Internal Medicine
University of Michigan

Disclosure(s): No financial relationships to disclose

Poster(s):

• (P-118) Patient Reported Outcomes (PRO) Analysis of the Phase 2 Multi-Center, Prospective, Randomized, Double-Blind Study Assessing Nitazoxanide for the Treatment of Norovirus in Hematopoietic Stem Cell and Solid Organ Transplant Recipients
  Thursday, October 17, 2024

  12:15 PM - 1:30 PM US PT